Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: OPHIREX, INC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2022-04-05 to 2025-12-04
Current total value of award: $23443943.61
Description: FOLLOW ON PHASE III MEDICAL R&D SBIR FOR PROJECT TITLED BROAD-SPECTRUM SNAKEBITE ANTIDOTE ORAL PRODUCT DEVELOPMENT AND IV CLINICAL STUDY